Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study
2007

IL-1 Receptor Antagonist Reduces Matrix Degradation in Human Intervertebral Discs

Sample size: 31 publication Evidence: high

Author Information

Author(s): Le Maitre Christine L, Hoyland Judith A, Freemont Anthony J

Primary Institution: University of Manchester

Hypothesis

Matrix degradation in degeneration of the intervertebral disc (IVD) is inhibited by IL-1 receptor antagonist (IL-1Ra).

Conclusion

IL-1Ra can significantly inhibit matrix degradation in degenerate intervertebral discs.

Supporting Evidence

  • IL-1Ra delivered directly onto explants of degenerate IVDs eliminates matrix degradation.
  • There is a direct relationship between matrix degradation and MDP expression.
  • Single injections of IVD cells engineered to over-express IL-1Ra significantly inhibit MDP expression for two weeks.

Takeaway

This study shows that a special medicine called IL-1Ra can help stop damage in the discs of our spine that can cause back pain.

Methodology

The study used in situ zymography and immunohistochemistry to assess matrix degradation and enzyme expression in human intervertebral disc samples.

Limitations

The study was conducted on human tissue samples, which may limit the generalizability of the findings.

Participant Demographics

The study included 18 cadaveric samples and 13 live patients, with a mix of ages and both sexes.

Statistical Information

P-Value

p < 0.01

Statistical Significance

p < 0.01

Digital Object Identifier (DOI)

10.1186/ar2282

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication